首页 | 本学科首页   官方微博 | 高级检索  
     

我院160例酪氨酸激酶抑制剂致不良反应分析
引用本文:叶晓兰,陈晶晶,张春红,石大伟,胡卢丰,张秀华. 我院160例酪氨酸激酶抑制剂致不良反应分析[J]. 中国药房, 2012, 0(42): 3997-3999
作者姓名:叶晓兰  陈晶晶  张春红  石大伟  胡卢丰  张秀华
作者单位:温州医学院附属第一医院药剂科,浙江温州325000
摘    要:
目的:观察酪氨酸激酶抑制剂治疗癌症的不良反应。方法:定期随访服用酪氨酸激酶抑制剂的160例患者,对其服药后的情况进行分析、总结。结果:酪氨酸酶抑制剂引起的不良反应以皮肤系统损害最为常见(占43.88%),其次是消化系统和呼吸系统。结论:临床上要对使用酪氨酸酶抑制剂的患者加强监测,以免严重不良反应的发生。

关 键 词:表皮生长因子受体  酪氨酸激酶抑制剂  药品不良反应

Analysis of 160 Cases of Adverse Drug Reaction of Tyrosine Kinase Inhibitor in Our Hospital
YE Xiao-lan,CHEN Jing-jing,ZHANG Chun-hong,SHI Da-wei,HU Lu-feng,ZHANG Xiu-hua. Analysis of 160 Cases of Adverse Drug Reaction of Tyrosine Kinase Inhibitor in Our Hospital[J]. China Pharmacy, 2012, 0(42): 3997-3999
Authors:YE Xiao-lan  CHEN Jing-jing  ZHANG Chun-hong  SHI Da-wei  HU Lu-feng  ZHANG Xiu-hua
Affiliation:(Dept. of Pharma- cy, The First Affiliated Hospital of Wenzhou Medical College, Zhejiang Wenzhou 325000, China)
Abstract:
OBJECTIVE: To observe adverse drug reactions (ADR) of tyrosine kinase inhibitors in the treatment of cancer. METHODS: 160 patients who took tyrosine kinase inhibitors were followed up regularly, and their conditions were summarized and analyzed after medication. RESULTS: The most common ADR caused by tyrosine kinase inhibitor was lesion of skin damage (43.88%), followed by digestive system and respiratory system. CONCLUSION: We should strengthen monitoring for patients who use tyrosine kinase inhibitors, so as to avoid the occurrence of serious ADR.
Keywords:Epidermal growth factor receptor  Tyrosine kinase inhibitor  Adverse drug reaction
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号